Skip to main content

Social Disadvantage Tied to Worse Lung Cancer Outcomes

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

THURSDAY, Sept. 28, 2023 -- Social disadvantage is associated with a lower likelihood of achieving textbook oncological outcome and worse survival in patients with non-small cell lung cancer (NSCLC), according to a study published online Sept. 19 in JTCVS Open.

Ahmed Alnajar, M.D., M.S.P.H., from the University of Miami, and colleagues examined whether social determinants of health can affect both achievement of textbook oncological outcome and overall survival (OS) in patients with surgically resected NSCLC with pathological nodal disease. The analysis included 11,274 patients with NSCLC receiving lobectomy resection, of which 48 percent had textbook oncological outcome.

The researchers found that 15 percent of patients were considered disadvantaged (two or more social determinants of health not met), which was associated with a lower likelihood of achieving textbook oncological outcome (adjusted odds ratio, 0.85) compared with non-socially disadvantaged patients. Further, patients achieving textbook oncological outcome had lower overall mortality (adjusted hazard ratio, 0.78) than patients not achieving textbook oncological outcome. Social disadvantage remained an independently significant risk factor with OS versus not being socially disadvantaged (adjusted hazard ratio, 1.24). The impact of social disadvantage on OS was significant, regardless of textbook oncological outcome status.

"Addressing social determinants of health is important to optimize care and long-term survival of this patient population," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

One in Nine U.S. Children Have Ever Been Diagnosed With ADHD

THURSDAY, May 23, 2024 -- Diagnoses of attention-deficit/hyperactivity disorder (ADHD) in U.S. children continue to increase, with approximately one in nine having ever received a...

2024 ASCO Annual Meeting to Focus on Clinical Cancer Research Impacting Patient Care

THURSDAY, May 23, 2024 -- The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held May 31 to June 4, 2024, in Chicago and online. The theme of this...

Socioeconomic Status Transitions Tied to Dementia Risk

THURSDAY, May 23, 2024 -- Upward and downward socioeconomic status (SES) transitions are associated with the risk for dementia and the length of dementia-free periods during the...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.